sublingual delivery glp-1 receptor agonists for Weight Management Schematic illustration of monoagonists, dual
Description
, 2
Researchers are not measuring weight, A1C, or relapse rate
Neurogastroenterol Motil
1 Several health conditions, including diabetes and Polycystic Ovarian Syndrome (PCOS), can affect the amount of GLP-1 released in the body or weaken the sensitivity of the receptors it binds to, leading to insulin resistance
Phillips SM
